Patents by Inventor Robert Davis

Robert Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180271862
    Abstract: The disclosure provides new transmucosal and subcutaneous pharmaceutical compositions comprising 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or 1-(4-fluoro-phenyl)-4-((6bR,10aS)-2,2-d2-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or comprising -(4-fluoro-phenyl)-4-((6bR,10aS)-1,1,2,2-d4-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, in free base, co-crystal or salt form, together with methods of making and using them.
    Type: Application
    Filed: March 23, 2018
    Publication date: September 27, 2018
    Inventors: Peng LI, Wei YAO, Robert DAVIS
  • Patent number: 10077267
    Abstract: The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT2A receptor, serotonin transporter (SERT) and/or pathways involving dopamine D1/D2 receptor signaling systems, and/or the treatment of residual symptoms.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: September 18, 2018
    Assignee: INTRA-CELLULAR THERAPIES, INC.
    Inventors: Sharon Mates, Peng Li, Lawrence P. Wennogle, Robert Davis
  • Patent number: 10072010
    Abstract: The invention relates to substituted pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]-quinoxaline compounds, represented by Formula 1, defined herein, free base or pharmaceutically acceptable salt forms of the compounds, pharmaceutical compositions thereof, and methods of treating conditions of the central nervous system therewith:
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: September 11, 2018
    Assignee: INTRA-CELLULAR THERAPIES, INC.
    Inventors: Peng Li, Qiang Zhang, Robert Davis, Lawrence P. Wennogle
  • Patent number: 10033623
    Abstract: A method for connecting endpoints. The method may include determining, using a first group of software threads, cross-connection information regarding various cross-connections among various network elements. The network elements may include a first network element and a second network element. The method may further include determining, using the first group of software threads, link information regarding various links between the network elements. The method may further include processing, within a network cache, the cross-connection information and the link information into various network resources groups. Each network resource group of the network resources groups may describe adjacent cross-connections for a link among the links.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: July 24, 2018
    Assignee: Ciena Corporation
    Inventors: Ankur Jain, Deepinder Gill, Nigel Robert Davis, Amal Karboubi
  • Publication number: 20180200256
    Abstract: The disclosure provides the use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals for the treatment of residual symptoms of psychosis or schizophrenia. The disclosure also provides novel long acting injectable formulations of particular substituted heterocycle fused gamma-carboline compounds and use of such long acting injectable formulations for the treatment of residual symptoms of psychosis or schizophrenia.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Applicant: INTRA-CELLULAR THERAPIES, INC.
    Inventors: Kimberly VANOVER, Peng LI, Sharon MATES, Robert DAVIS, Lawrence P. WENNOGLE
  • Patent number: 10022561
    Abstract: A radiotherapy apparatus and method, comprising a source of radiation for delivering pulses of radiation at a base frequency; and a control unit configured to generate a time-averaged power level of x by generating an nth pulse when n is equal to the rounded value of an integer multiple of 1/x, where x is a value between 0 and 1 representing a proportion of a maximum power output of the radiotherapy apparatus. The pulses may form a repeating pulse train pattern, and the control unit may comprise a processing unit configured to provide a pulse train pattern having a number of available slots, the slots being marked as a permitted pulse or a suppressed pulse.
    Type: Grant
    Filed: July 26, 2016
    Date of Patent: July 17, 2018
    Assignee: Elekta Limited
    Inventors: Robert Davis, Peter Davis
  • Publication number: 20180197431
    Abstract: A wireless client device having a touchscreen may run a class assessment tool. The tool may have an interface that displays a row of student pictures and names and enables a teacher to assess the students on various key aspects. The tool may display a rubric for each key aspect when the key aspect is hovered over or selected. The interface may include a matrix of assessment blocks having a plurality of individually selectable areas that enable a teacher to enter a key aspect score for each key aspect for each student. The interface may include a row of comment areas configured to receive a private message for a student and a row of final scores based on the key aspect scores of the student. A row of results may be displayed, where each result reflects whether a student passed or failed the class based on the student's final score.
    Type: Application
    Filed: December 11, 2017
    Publication date: July 12, 2018
    Inventors: Kenneth Robert DAVIS, Ian WOOD, Mollie Christina WOLCOTT
  • Publication number: 20180197432
    Abstract: A wireless client device having a touchscreen may run a class assessment tool. The tool may have an interface that displays a row of student pictures and names and enables a teacher to assess the students on various key aspects. The tool may display a rubric for each key aspect when the key aspect is hovered over or selected. The interface may include a matrix of assessment blocks having a plurality of individually selectable areas that enable a teacher to enter a key aspect score for each key aspect for each student. The interface may include a row of comment areas configured to receive a private message for a student and a row of final scores based on the key aspect scores of the student. A row of results may be displayed, where each result reflects whether a student passed or failed the class based on the student's final score.
    Type: Application
    Filed: December 11, 2017
    Publication date: July 12, 2018
    Inventors: Kenneth Robert DAVIS, Ian WOOD, Mollie Christina WOLCOTT
  • Publication number: 20180177782
    Abstract: The invention relates to the administration of inhibitors of phosphodiesterase 1 (PDE1) for the treatment of diseases or disorders characterized by disruption of or damage to various cGMP/PKG mediated pathways. In one embodiment the invention relates to inhibitors of phosphodiesterase 1 (PDE1) for treatment of cardiovascular disease and related disorders, e.g., congestive heart disease, atherosclerosis, myocardial infarction, and stroke.
    Type: Application
    Filed: September 19, 2017
    Publication date: June 28, 2018
    Applicant: INTRA-CELLULAR THERAPIES, INC.
    Inventors: Lawrence P. Wennogle, Robert Davis
  • Publication number: 20180160929
    Abstract: The present approach relates to the fabrication and use of a probe array having multiple individual probes. In one embodiment, the probes of the probe array may be functionalized such that certain of the probes are suitable for electrical sensing (e.g., recording) or stimulation, non-electrical sensing or stimulation (e.g., chemical sensing and/or release of biomolecules when activated), or a combination of electrical and non-electrical sensing or stimulation.
    Type: Application
    Filed: December 13, 2016
    Publication date: June 14, 2018
    Inventors: Jeffrey M. Ashe, Kaustubh Ravindra Nagarkar, Christopher Michael Puleo, Christopher Fred Keimel, Craig Patrick Galligan, Yizhen Lin, Nancy Cecelia Stoffel, Richard Vanfleet, Robert Davis, Guohai Chen
  • Patent number: 9983355
    Abstract: An optical coupler can be provided for coupling a light beam into a waveguide. The optical coupler can include a stepped structure, such as to reduce difficulties during manufacture, reduce expenses associated with manufacture, and additionally, to provide an increased acceptance angle of the optical coupler. The waveguide can include a guiding region where a cladding thickness can be increased relative to a coupling region, such as to reduce losses due to evanescent outcoupling in the guiding region.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: May 29, 2018
    Assignee: Analog Devices, Inc.
    Inventors: Scott Robert Davis, Shrenik Deliwala, Michael Ziemkiewicz, Derek Gann, Andrew William Sparks, Michael Howard Anderson
  • Publication number: 20180139112
    Abstract: A system and method for dynamically obtaining data associated with a performance metric associated with access devices associated with a resource provider in a specific geographic location and comparing it to data associated with the performance of other access devices associated with another resource provider is disclosed. A processing server computer can perform the comparison and may provide the comparison to a user device, so that corrective action, if any, may be taken.
    Type: Application
    Filed: November 15, 2017
    Publication date: May 17, 2018
    Inventors: Robert Davis, Nitin Kumar, Justin George
  • Patent number: 9956227
    Abstract: The disclosure provides the use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals for the treatment of residual symptoms of psychosis or schizophrenia. The disclosure also provides novel long acting injectable formulations of particular substituted heterocycle fused gamma-carboline compounds and use of such long acting injectable formulations for the treatment of residual symptoms of psychosis or schizophrenia.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: May 1, 2018
    Assignee: INTRA-CELLULAR THERAPIES, INC.
    Inventors: Kimberly Vanover, Peng Li, Sharon Mates, Robert Davis, Lawrence P. Wennogle
  • Patent number: 9951815
    Abstract: A pitch bearing assembly for a wind turbine may include an outer race and an inner race rotatable relative to the outer race. The inner race may define an inner circumference and may include a plurality of gear teeth around the inner circumference. The inner race may also include a circumferential flange extending at least partially around the inner circumference. In addition, the pitch bearing assembly may include a stiffener coupled to the circumferential flange.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: April 24, 2018
    Assignee: GENERAL ELECTRIC COMPANY
    Inventors: Adam Daniel Minadeo, William Francis Gevers, Robert Davis Pine, Andreas Schubert
  • Publication number: 20180077575
    Abstract: Embodiments described herein provide approaches for associating a user identity to a wireless signal based on information received at an access point. Specifically, when a first user presents a set of user credentials to a physical access point, his/her profile is accessed to authenticate the first user. A set of wireless signals emanating from one or more wireless devices operated by the first user is also received at the physical access point and associated with the first user. Information about the first user may then be broadcast and accessed by a second user (e.g., via his/her mobile device) in proximity to the first user and in receipt of the set of wireless signals associated with the first user.
    Type: Application
    Filed: November 9, 2017
    Publication date: March 15, 2018
    Inventors: Eric M. Anderson, Robert A. Davis, Christopher J. Dawson, Salvatore T. Lococo
  • Patent number: 9888378
    Abstract: Embodiments described herein provide approaches for associating a user identity to a wireless signal based on information received at an access point. Specifically, when a first user presents a set of user credentials to a physical access point, his/her profile is accessed to authenticate the first user. A set of wireless signals emanating from one or more wireless devices operated by the first user is also received at the physical access point and associated with the first user. Information about the first user may then be broadcast and accessed by a second user (e.g., via his/her mobile device) in proximity to the first user and in receipt of the set of wireless signals associated with the first user.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: February 6, 2018
    Assignee: International Business Machines Corporation
    Inventors: Eric M. Anderson, Robert A. Davis, Christopher J. Dawson, Salvatore T. Lococo
  • Publication number: 20180026852
    Abstract: A processor receives service availability data for at least one service, where the service availability data indicates an amount time the at least one service was available and an amount of time one or more resources utilized in the service was available. A processor receives service configuration data for the service, where the service configuration data indicates one or more resource requirements of the at least one service. A processor determines one or more resource unavailability scores for the one or more resources utilized in providing the service. A processor determines one or more resource replacement scores for the one or more resources utilized in the service. A processor determines availability risk scores for the at least one service based on the one or more resource unavailability scores and the one or more resource replacement scores. A processor generates an indication of at-risk services of the at least one service.
    Type: Application
    Filed: July 21, 2016
    Publication date: January 25, 2018
    Inventors: Eric M. Anderson, Robert A. Davis, Terry L. Keebaugh, Eric K. Watson
  • Publication number: 20180000825
    Abstract: The invention relates to the administration of inhibitors of phosphodiesterase 1 (PDE1) for the treatment of diseases or disorders characterized by disruption of or damage to various cGMP/PKG mediated pathways. In one embodiment the invention relates to inhibitors of phosphodiesterase 1 (PDE1) for treatment of cardiovascular disease and related disorders, e.g., congestive heart disease, atherosclerosis, myocardial infarction, and stroke.
    Type: Application
    Filed: September 19, 2017
    Publication date: January 4, 2018
    Applicant: INTRA-CELLULAR THERAPIES, INC.
    Inventors: Lawrence P. Wennogle, Robert Davis
  • Patent number: 9858162
    Abstract: A method for dynamically assembling a mobile application includes the steps of: (i) receiving a first probability of a potential failure occurring within a first computing environment; (ii) comparing the first probability to a first threshold; (iii) automatically provisioning a first portion of a second computing environment in response to the first probability exceeding the first threshold; (iv) receiving a second probability of the potential failure occurring within the first computing environment; (v) comparing the second probability to a second threshold; and (vi) automatically provisioning a second portion of the second computing environment in response to the second probability exceeding the second threshold.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: January 2, 2018
    Assignee: International Business Machines Corporation
    Inventors: Eric M. Anderson, Christopher J. Dawson, Robert A. Davis, Patti Foley
  • Publication number: 20170319580
    Abstract: The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving the 5-HT2A receptor, the serotonin transporter (SERT), pathways involving the dopamine D1 and D2 receptor signaling system, and/or the ?-opioid receptor.
    Type: Application
    Filed: July 26, 2017
    Publication date: November 9, 2017
    Inventors: Wei YAO, Peng LI, Robert DAVIS, Sharon MATES, Kimberly VANOVER, Gretchen SNYDER